Search Media Items

Resumen de información revisada por expertos sobre el uso de los hongos medicinales como tratamiento para las personas con cáncer.

Information about the ways in which clinical trial participants are protected before and during the conduct of a study.

As NCI's central scientific strategy office, CRS collaborates with the institute's divisions, offices, and centers to identify research opportunities to advance NCI's vision for the future of cancer research.

Scientific review ensures that studies are based on sound science, which contributes to the safety of clinical trial participants. Learn about the role of Institutional Review Boards (IRBs), Data and Safety Monitoring Boards (DSMBs), and government agenci

TMIST es un estudio aleatorizado de exámenes de detección de cáncer de seno que compara dos tipos de mamografía digital aprobados por la FDA, la mamografía digital (2-D) convencional con una tecnología más nueva llamada mamografía de tomosíntesis (3-D).

While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 3 and 4.

A summary of clinical trial results showing that daratumumab plus lenalidomide and dexamethasone improved progression-free survival for patients with relapsed or refractory disease.

NCI and FDA collaborate to train physicians in aspects of drug, biologic, or device development and standards for assessing medical product safety. Learn more about this cancer training program.

Learn about the different types of costs related to taking part in a clinical trial, who is expected to pay for which costs, and tips for working with insurance companies.

NCI's Center for Cancer Genomics uses functional genomics to understand the impact of cancer genes and pathways, and how to target them effectively.